Dyevoich, Allison M, and Karen M Haas.
"Type I IFN, Ly6C+ cells, and phagocytes support suppression of peritoneal carcinomatosis elicited by a TLR and CLR agonist combination." Molecular Cancer Therapeutics
(2020):
molcanther.0885.2019.
Web. 05 Aug. 2020.
